Session Details
[2-MO18]JSNM Oral 18:Prostate Radionuclide Therapy 1／Keynote Lecture 04
Fri. Nov 20, 2026 8:30 AM - 9:30 AM JST
Fri. Nov 20, 2026 11:30 PM - 12:30 AM UTC
Fri. Nov 20, 2026 11:30 PM - 12:30 AM UTC
Room 2（2F Medium Hall）
Chair: Tatsuya Higashi (Dept. of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, QST), Hiroshi Wakabayashi (Nuclear Medicine, Kanazawa University Hospital)
[2-MO18-01]PSA Doubling Time Before the Second Radium-223 Cycle Predicts Overall Survival in mCRPC
Tsu-Kang Chen, Yen-Hsiang Chang (Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, Taiwan)
[2-MO18-02]Lesion detection discrepancy: 68Ga-PSMA-11 PET/CT vs SPECT/CT after initial 177Lu-PSMA-617
Takuya Seko1, Nobuyuki Kawai1, Keita Fujimoto1, Masaya Ito1, Takahide Maeda1, Nao Yamada1, Shoichi Azuma1, Kaito Ikawa1, Koji Iinuma2, Takuya Koie2, Masayuki Matsuo1 (1.Department of Radiology, The University of Gifu, Gifu, Japan, 2.Department of Urology, Graduate School of Medicine, Gifu University, Gifu, Japan.)
[2-MO18-03]A Study of Physiological Uptake in 68Ga-PSMA PET and 177Lu-PSMA Scintigraphy
Tokiko Abe1, Takurou Isoda1, Yoshiyuki Kitamura1, Masaoki Kusunoki1, Motohiro Sando1, Shingo Baba2, Kosei Ishigami1 (1.Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2.Department of Health Sciences, School of Medicine, Kyushu Univercity, Fukuoka, Japan)
[2-MO18-04]Predictors of 16uSv/h Discharge Time After Lu-PSMA: Role of Bone Uptake & Cycle Number
Onuki Koji1, Shota Takemoto1, Fumitaka Kumagai1, Mio Yasunaga1, Shunsuke Yoshida1, Keiko Tanimoto1, Satoshi Kimura1, Yoshie Omiya2, Yosuke Kogure1, Mitsuaki Tatsumi2 (1.Department of Radiology, Juntendo University Hospital, Tokyo, Japan, 2.Diagnostic Radiology, Juntendo University Hospital, Tokyo, Japan)
[KL01-04]PSMA Theranostics in Prostate Cancer: Taiwan Experience and Future Perspectives
Kelvin Ching-Chu Lu (Department of Nuclear Medicine, National Taiwan University Cancer Center, Taiwan)